Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. (Endocrine-related cancer, 2009)

(untitled) - Dworakowska, D; Wlodek, E; Leontiou, C; Igreja, S; Cakir, M; Teng, M; Prodromou, N; Góth, M; Grozinsky-Glasberg, S; Gueorguiev, M; Kola, B; Korbonits, M; et al.